Not applicableActive Not RecruitingNCT07244744What this trial is testingTilrdakizumab AlmirallWho this might be right forPsoriasis University Hospital Schleswig-Holstein 3
Post-approval studies (Phase 4)Study completedNCT00655564What this trial is testingLong-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type PsoriasisWho this might be right forPsoriasis Wake Forest University 15
Not applicableStudy completedNCT05959070What this trial is testingAn Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)Who this might be right forPsoriasis AbbVie 154
Post-approval studies (Phase 4)Study completedNCT04229836What this trial is testingEfficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)Who this might be right forPlaque Psoriasis Almirall, S.A. 178
Large-scale testing (Phase 3)Study completedNCT05108766What this trial is testingA Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype PsoriasisWho this might be right forPlaque Psoriasis Shenzhen Kangzhe Pharmaceutical Co., Ltd. 220
Large-scale testing (Phase 3)Study completedNCT07712705What this trial is testingHPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.Who this might be right forPsoriasis Newsoara Biopharma Co., Ltd. 515
Testing effectiveness (Phase 2)Study completedNCT05858047What this trial is testingAn Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque PsoriasisWho this might be right forEffects, Drug Side CSPC Ouyi Pharmaceutical Co., Ltd. 93
Large-scale testing (Phase 3)Study completedNCT02748863What this trial is testingStudy of Secukinumab With 2 mL Pre-filled SyringesWho this might be right forPsoriasis Novartis Pharmaceuticals 214
Large-scale testing (Phase 3)Study completedNCT01186744What this trial is testingEvaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 666
Testing effectiveness (Phase 2)Study completedNCT02852967What this trial is testingA Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Kadmon Corporation, LLC 110
Testing effectiveness (Phase 2)Study completedNCT02762994What this trial is testingInternational Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Biocad 120
Large-scale testing (Phase 3)Study completedNCT00096603What this trial is testingEvaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600gWho this might be right forPsoriasis Genentech, Inc. 450
Not applicableStudy completedNCT05863273What this trial is testingReal World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）Who this might be right forPsoriasis First Hospital of China Medical University 360
Testing effectiveness (Phase 2)Study completedNCT02905006What this trial is testingStudy to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT04713592What this trial is testingStudy of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar InvolvementWho this might be right forPsoriasis AbbVie 174
Large-scale testing (Phase 3)Study completedNCT06108544What this trial is testingA Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment PeriodWho this might be right forPlaque Psoriasis Takeda 1,108
Not applicableStudy completedNCT02786186What this trial is testingA Registry of Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Novartis Pharmaceuticals 2,376
Not applicableStudy completedNCT01084668What this trial is testingQuality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic DrugsWho this might be right forPsoriasis Chronic Abbott 46
Large-scale testing (Phase 3)Study completedNCT01690299What this trial is testingPhase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisWho this might be right forPsoriasisPsoriatic Arthritis Amgen 250
Not applicableStudy completedNCT05155098What this trial is testing2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial SpondyloarthritisWho this might be right forModerate to Severe Plaque PsoriasisPsoriatic ArthritisAnkylosing Spondylitis+1 more Novartis Pharmaceuticals 127